We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

43 hedge funds and large institutions have $28.1M invested in Bio-Path Holdings Inc in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 4

7% less funds holding

Funds holding: 4643 (-3)

30% less capital invested

Capital invested by funds: $39.9M → $28.1M (-$11.8M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
43
Holders Change
-3
Holders Change %
-6.52%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
4
Increased
17
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ProShare Advisors
51
ProShare Advisors
Maryland
-$20K -3 Closed
AIM
52
Acrospire Investment Management
Illinois
-$17K -2 Closed
Walleye Trading
53
Walleye Trading
New York
-$4K -1 Closed
Federated Hermes
54
Federated Hermes
Pennsylvania
-$3K

BPTH Hedge Fund Activity: Q3 2016 in Review

43 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2016, worth a combined $28.1M — down 30% from $39.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BPTH and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 17 added.

The largest buyer was Raymond James Financial Services Advisors, adding an estimated $3.14M. The largest seller was Sabby Management, cutting an estimated $2.68M.

  • 43 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2016, down from 46 in Q2 2016.
  • Funds reported $28.1M of Bio-Path Holdings Inc stock for Q3 2016, down 30% quarter-over-quarter.
  • 4 funds opened new Bio-Path Holdings Inc positions in Q3 2016 and 7 closed out, a net change of -3 holders.
  • The largest Bio-Path Holdings Inc buyer in Q3 2016 was Raymond James Financial Services Advisors, an estimated $3.14M added.
  • The largest Bio-Path Holdings Inc seller in Q3 2016 was Sabby Management, an estimated $2.68M sold.

Based on aggregated 13F filings for Q3 2016.